Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Revenue (2023 - 2025)

Historic Revenue for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $683000.0.

  • Upstream Bio's Revenue rose 1252.06% to $683000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 2682.37%. This contributed to the annual value of $2.4 million for FY2024, which is 42.02% down from last year.
  • Latest data reveals that Upstream Bio reported Revenue of $683000.0 as of Q3 2025, which was up 1252.06% from $937000.0 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Revenue ranged from a high of $937000.0 in Q2 2025 and a low of $450000.0 during Q4 2023
  • For the 3-year period, Upstream Bio's Revenue averaged around $625222.2, with its median value being $613000.0 (2024).
  • The largest annual percentage gain for Upstream Bio's Revenue in the last 5 years was 8372.55% (2025), contrasted with its biggest fall of 1156.25% (2025).
  • Upstream Bio's Revenue (Quarter) stood at $450000.0 in 2023, then soared by 36.22% to $613000.0 in 2024, then rose by 11.42% to $683000.0 in 2025.
  • Its Revenue was $683000.0 in Q3 2025, compared to $937000.0 in Q2 2025 and $566000.0 in Q1 2025.